CKDkb: a knowledge base and platform for drug development against non-alcoholic fatty liver disease

Clinical Trial Details

Trial ID:	L4333
Source ID:	NCT01892319
Associated Drug:	Insulin Detemir
Title:	An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
Acronym:
Status:	COMPLETED
Study Results:	NO
Results:
Conditions:	Diabetes Mellitus\|Diabetes Mellitus, Type 1\|Diabetes Mellitus, Type 2
Interventions:	DRUG: insulin detemir\|DRUG: other injectable antidiabetic treatment regimens
Outcome Measures:	Primary: Proportion of pregnancies (Levemir® treatment), compared to pregnancies (other basal insulin treatment regimens), resulting in none of the following events: Major congenital malformations, Perinatal death, Neonatal death, Assessed up to 4 weeks after delivery \| Secondary: Incidence of major hypoglycaemia, During pregnancy\|Proportion of pregnancies complicated by pre-eclampsia, During pregnancy\|Proportion of pregnancies resulting in perinatal death, Assessed 1 week after delivery\|Proportion of pregnancies resulting in neonatal death, Assessed 4 weeks after delivery\|Proportion of pregnancies resulting in spontaneous abortion, Assessed at pregnancy termination\|Proportion of pregnancies resulting in pre-term delivery, Assessed at delivery\|Height, At the age of 1 year\|Weight, At the age of 1 year\|Proportion with changes (progression/regression) of major congenital malformations, At the age of 1 year
Sponsor/Collaborators:	Sponsor: Novo Nordisk A/S
Gender:	FEMALE
Age:	CHILD, ADULT, OLDER_ADULT
Phases:
Enrollment:	2446
Study Type:	OBSERVATIONAL
Study Designs:	Observational Model: \|Time Perspective: p
Start Date:	2013-09-30
Completion Date:	2019-09-30
Results First Posted:
Last Update Posted:	2019-11-19
Locations:	Novo Nordisk Investigational Site, Zagreb, 10000, Croatia\|Novo Nordisk Investigational Site, Pori, 28500, Finland\|Novo Nordisk Investigational Site, Tampere, 33521, Finland\|Novo Nordisk Investigational Site, Turku, 20520, Finland\|Novo Nordisk Investigational Site, Angers, 49000, France\|Novo Nordisk Investigational Site, Corbeil Essonnes, 91106, France\|Novo Nordisk Investigational Site, Lille, 59037, France\|Novo Nordisk Investigational Site, Nimes, 30006, France\|Novo Nordisk Investigational Site, Paris, 75014, France\|Novo Nordisk Investigational Site, TOULOUSE cedex, 31054, France\|Novo Nordisk Investigational Site, Valenciennes, 59322, France\|Novo Nordisk Investigational Site, Bramsche, 49565, Germany\|Novo Nordisk Investigational Site, Eisenach, 99817, Germany\|Novo Nordisk Investigational Site, Essen, 45136, Germany\|Novo Nordisk Investigational Site, Friedrichsthal, 66299, Germany\|Novo Nordisk Investigational Site, Ludwigshafen, 67059, Germany\|Novo Nordisk Investigational Site, Neuwied, 56564, Germany\|Novo Nordisk Investigational Site, Speyer, 67346, Germany\|Novo Nordisk Investigational Site, Stuttgart, 70184, Germany\|Novo Nordisk Investigational Site, Sulzbach-Rosenberg, 92237, Germany\|Novo Nordisk Investigational Site, Athens, GR-11528, Greece\|Novo Nordisk Investigational Site, Nea Efkarpia - Thessaloniki, GR-56403, Greece\|Novo Nordisk Investigational Site, Castlebar, Ireland\|Novo Nordisk Investigational Site, Co. Donegal, Ireland\|Novo Nordisk Investigational Site, Dublin 2, Ireland\|Novo Nordisk Investigational Site, Galway, H91 YR71, Ireland\|Novo Nordisk Investigational Site, Petach Tikva, 49100, Israel\|Novo Nordisk Investigational Site, Livorno, 57124, Italy\|Novo Nordisk Investigational Site, Milano, 20132, Italy\|Novo Nordisk Investigational Site, Padova, 35143, Italy\|Novo Nordisk Investigational Site, Roma, 00189, Italy\|Novo Nordisk Investigational Site, Roma, 00195, Italy\|Novo Nordisk Investigational Site, Sant'Andrea Delle Fratte (PG), 06129, Italy\|Novo Nordisk Investigational Site, Torino, 10126, Italy\|Novo Nordisk Investigational Site, Trento, 38122, Italy\|Novo Nordisk Investigational Site, Verona, 37126, Italy\|Novo Nordisk Investigational Site, Alor Gajah, 78300, Malaysia\|Novo Nordisk Investigational Site, Alor Setar, 05400, Malaysia\|Novo Nordisk Investigational Site, Alor Setar, 05460, Malaysia\|Novo Nordisk Investigational Site, Batu Caves, 68100, Malaysia\|Novo Nordisk Investigational Site, Ipoh, 30450, Malaysia\|Novo Nordisk Investigational Site, Ipoh, 31400, Malaysia\|Novo Nordisk Investigational Site, Kuala Lumpur, 52000, Malaysia\|Novo Nordisk Investigational Site, Kuala Lumpur, 57000, Malaysia\|Novo Nordisk Investigational Site, Kuala Lumpur, 59100, Malaysia\|Novo Nordisk Investigational Site, Putrajaya, 62250, Malaysia\|Novo Nordisk Investigational Site, Seremban, 70300, Malaysia\|Novo Nordisk Investigational Site, Seremban, 70450, Malaysia\|Novo Nordisk Investigational Site, Amsterdam, 1081 HV, Netherlands\|Novo Nordisk Investigational Site, Apeldoorn, 7334 DZ, Netherlands\|Novo Nordisk Investigational Site, Arnhem, 6815 AD, Netherlands\|Novo Nordisk Investigational Site, Eindhoven, 5631 BM, Netherlands\|Novo Nordisk Investigational Site, Utrecht, 3584 CX, Netherlands\|Novo Nordisk Investigational Site, Bergen, 5021, Norway\|Novo Nordisk Investigational Site, Gjøvik, NO-2819, Norway\|Novo Nordisk Investigational Site, Hamar, 2318, Norway\|Novo Nordisk Investigational Site, Lillehammer, 2609, Norway\|Novo Nordisk Investigational Site, Moss, 1535, Norway\|Novo Nordisk Investigational Site, Tønsberg, 3116, Norway\|Novo Nordisk Investigational Site, Ålesund, 6026, Norway\|Novo Nordisk Investigational Site, Legnica, 59-220, Poland\|Novo Nordisk Investigational Site, Lodz, 90-553, Poland\|Novo Nordisk Investigational Site, Lubin, 59-300, Poland\|Novo Nordisk Investigational Site, Poznan, 60-371, Poland\|Novo Nordisk Investigational Site, Poznan, 61-693, Poland\|Novo Nordisk Investigational Site, Szczecin, 70-376, Poland\|Novo Nordisk Investigational Site, Almada, 2805-267, Portugal\|Novo Nordisk Investigational Site, Amadora, 2720-276, Portugal\|Novo Nordisk Investigational Site, Leiria, 2410-197, Portugal\|Novo Nordisk Investigational Site, Lisboa, 1069-089, Portugal\|Novo Nordisk Investigational Site, Lisboa, 1649-035, Portugal\|Novo Nordisk Investigational Site, Porto, 4099-001, Portugal\|Novo Nordisk Investigational Site, Porto, 4200-319, Portugal\|Novo Nordisk Investigational Site, Timisoara, Timis, 300736, Romania\|Novo Nordisk Investigational Site, Bucharest, 020042, Romania\|Novo Nordisk Investigational Site, Bucharest, 020359, Romania\|Novo Nordisk Investigational Site, Bucharest, 020475, Romania\|Novo Nordisk Investigational Site, Bucharest, 022441, Romania\|Novo Nordisk Investigational Site, Galati, 800098, Romania\|Novo Nordisk Investigational Site, Barcelona, 08025, Spain\|Novo Nordisk Investigational Site, Barcelona, 08036, Spain\|Novo Nordisk Investigational Site, Madrid, 28046, Spain\|Novo Nordisk Investigational Site, Málaga, 29006, Spain\|Novo Nordisk Investigational Site, Sevilla, 41014, Spain\|Novo Nordisk Investigational Site, Valencia, 46026, Spain\|Novo Nordisk Investigational Site, Bath, BA1 3NG, United Kingdom\|Novo Nordisk Investigational Site, Belfast, BT12 6BA, United Kingdom\|Novo Nordisk Investigational Site, Bristol, BS10 5NB, United Kingdom\|Novo Nordisk Investigational Site, Devon, EX2 5DW, United Kingdom\|Novo Nordisk Investigational Site, Glasgow, G31 2ER, United Kingdom\|Novo Nordisk Investigational Site, Inverness, IV2 3JH, United Kingdom\|Novo Nordisk Investigational Site, Southampton, SO16 5YA, United Kingdom\|Novo Nordisk Investigational Site, Stevenage, SG1 4AB, United Kingdom
URL:	https://clinicaltrials.gov/show/NCT01892319

Knowledge Graph
Associated Data

Drug ID	Drug Name	Type	DrugBank ID	Targets	Category	Latest Progress

Clinical Trial Details

Summary

Knowledge Graph

Associated Data

Associated NAFLD Drugs (0)